Table 1 Demographic and medical characteristics
Medical characteristics upon admission to ICU | |
|---|---|
Age (yr) | 62 [51–69] |
Sex (F/M) | 20/40 |
BMI (kg.m−2) | 27 [22–30] |
SAPS II score | 36 [28–44] |
SOFA score | 6 [4–8] |
Reason for admission to the ICU | |
Liver transplant, n (%) | 18 (30%) |
Post-operative, n (%) | 17 (28%) |
ARDS, n (%) | 6 (10%) |
Hemorrhagic shock, n (%) | 5 (8%) |
Septic shock, n (%) | 4 (7%) |
Others, n (%) | 10 (17%) |
Characteristics upon enrolment into the study | |
RASS level | 0 [0–0] |
CAM-ICU negative, n (%) | 60 (100%) |
Length of stay in ICU before enrollment (days) | 2.7 [1.1–3.6] |
Invasive mechanical ventilation before enrollment, n (%) | 36 (60%) |
Time between extubation and enrollment (hours) | 25 [14–42] |
Sedation before enrollment, n (%) | 36 (60%) |
Number of tubes or catheters at inclusion | 4 [2–5] |
Medical characteristics of patients on the first relaxation session | |
Mechanical ventilation, n (%) | 1 (2%) |
Non-invasive ventilation, n (%) | 2 (3%) |
High flow nasal oxygen therapy, n (%) | 18 (30%) |
Dialysis, n (%) | 2 (3%) |
Vasopressors, n (%) | 7 (12%) |
Sedation at enrollment, n (%) | 0 (0%) |
Analgesic administration at enrollment, n (%) | 45 (75%) |
Acetaminophen, n (%) | 19 (32%) |
Nefopam, n (%) | 38 (63%) |
Tramadol, n (%) | 32 (53%) |
Major opioid, n (%) | 2 (3%) |
Epidural analgesia, n (%) | 3 (5%) |
Anxiolytic administration at enrollment, n (%) | 16 (27%) |
Patients’ outcomes | |
Length of stay in ICU (days) | 8.0 [5.2–12.1] |
Mortality in ICU, n (%) | 3 (5%) |
Total length of stay in hospital (days) | 21.8 [12.6–39.3] |
Total mortality in hospital, n (%) | 7 (12%) |